Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
about
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapy
P2860
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@ast
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@en
type
label
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@ast
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@en
prefLabel
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@ast
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@en
P2093
P2860
P1433
P1476
Gemcitabine and docetaxel as s ...... plus platinum-based regimens.
@en
P2093
A Onyenadum
H P Kalofonos
N Stavroyianni
N Tsavaris
P2860
P304
P356
10.1002/1097-0142(20011201)92:11<2902::AID-CNCR10103>3.0.CO;2-O
P407
P577
2001-12-01T00:00:00Z